Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression

Clinical trial NCT06866236 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06866236
Sponsor: Ebima Clifford Okundaye
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases Acute Kidney Injury Kidney Failure

Start date: 2025-10-01
Primary completion: 2026-10-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.